glp-1 news today As interest in medication grows, scammers are tricking consumers with fake alternatives. Click the link in bio to learn how to spot them A new study conducted by

Docimo Jr, S., Shah, J., Warren, G., Ganam, S., Sujka, J., & DuCoin, C

Clinical translation requires human CSF pharmacokinetic assays to prove BBB bypass, a rigorous dose-escalation Phase I trial to establish a safe human NOAEL for chronic dosing, and an RCT utilizing precise neurocognitive testing (e.g., MoCA) to confirm that murine transcriptomic shifts yield functional neuroprotection in humans

Additional information Enhanced Digital Features To view enhanced digital features for this article go to Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

Appearance: Blue powder

It is used in research for healing, tissue repair, and inflammation reduction